直 Japanese PDF Font
  • 我们的专业人员
  • 服务
  • 我们的见解
  • 办公室
  • 事务所
  • 人才招聘
Finnegan
Mareesa A. Frederick
Partner
More
vCard
  • 901 New York Avenue, NW
  • Washington, DC 20001-4413
+1 202 408 4383
mareesa.frederick@finnegan.com mareesa.frederick@finnegan.com

Mareesa A. Frederick

Partner

  • +1 202 408 4383 +1 202 408 4383
  • mareesa.frederick@finnegan.com mareesa.frederick@finnegan.com
  • 901 New York Avenue, NW
  • Washington, DC 20001-4413
  • vCard

Mareesa Frederick 律师的执业重点是复杂的高风险知识产权诉讼,尤其是美国国际贸易委员会(ITC)的337条款诉讼程序。她曾被《The Legal 500 U.S.》评为美国国际贸易委员会专利诉讼的“下一代律师”代表人物。此外,在向客户提供预审策略、战略许可机会和专利组合咨询服务领域,Mareesa也积累了丰富的经验。

Mareesa处理过众多技术领域的诉讼,包括化妆品、医药产品、制造工艺、生物技术、聚合物、半导体芯片和包装、运动疗法设备、可调谐激光器、移动电话、数码相机、电视和电脑显示器、喷墨墨盒、印刷板、LED照明和汽车零件。她还处理过外观设计专利、商标、商业秘密和商业外观索赔等诉讼案件。

在加入本所之前,Mareesa是美国国际贸易委员会的一名高级调查律师,在美国国际贸易委员会的众多337条款案件中担任首席政府法律顾问,涉及机械、电气和消费品相关专利。此外,她还曾在美孚化工薄膜事业部任职,在聚合物加工领域积累了丰富的技术经验,曾在该事业部担任研发工程师和工艺工程师。

Mareesa投入了大量的时间从事无偿法律援助。最近,Capital Pro Bono Honor Roll表彰了她的贡献。她通过华盛顿无家可归者法律诊所(Washington Legal Clinic for the Homeless)代理客户,并参与了飞翰的刑事法律援助计划,在华盛顿高等法院为客户提供代理服务。目前,她的无偿法律援助工作的重点是支持有特殊教育需求的儿童,她在飞翰领导建立正式特殊教育项目的相关事宜。

除了飞翰的专利执业外,Mareesa还担任霍华德大学的兼职教授六年,为工程专业的学生教授专利法,还曾在霍华德大学法学院担任兼职教授两年,教授专利法和专利政策课程。Mareesa的卓越贡献获得了《National Law Journal》的认可,该杂志称她为华盛顿地区“冉冉升起的明星”。

相关信息

重要经历

  • Eli Lilly and Company诉Actavis Labs.UTInc.案 在Cialis®相关专利诉讼中,代理Eli Lilly。
  • Actelion Pharmaceuticals诉ICOS Corp.案 在一项涉及药物配方的专利审判和上诉委员会(PTAB)诉讼中,代表ICOS参与诉讼。
  • Eli Lilly and Company诉Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center案 在专利审判和上诉委员会的一项专利双方复审案件判决的上诉中,代表Eli Lilly参与诉讼。
  • Nippon Steel & Sumitomo Metal Corp.诉POSCO案 在一项涉及晶粒钢的专利侵权诉讼中,为POSCO提供辩护。
  • 某L-色氨酸,L-色氨酸产品及其生产方法(Ajinomoto Co. Inc.诉CJ America, Inc.案)在一项美国国际贸易委员会调查和专利双方复审程序中,代表Ajinomoto参与并取得胜诉,案件涉及转基因生物及使用其批量生产商业的色氨酸的专利。根据美国国际贸易委员会的最终判决,Ajinomoto专利有效且受到侵犯,同时美国国际贸易委员会发布了有限停止和终止令,禁止CJ和其他被告进口并在美国销售侵权产品。专利审判和上诉委员会针对CJ提出的两项挑战专利有效性的申请拒绝立案。
  • 某鞋类产品(Converse Inc.诉Various Retailers案)在一项涉及Converse主张Chuck Taylor All Star运动鞋侵犯其商标权的调查中,代表被告零售商并取得胜诉。委员会判定,Converse主张的商标无效。
  • 2015-2016,美国联邦巡回上诉法院律师协会全球会员。
  • 2014年,法律多元化理事会成员。
  • 2009年至2015年,担任Elsie Whitlow Stokes特许学校的秘书兼管理主席。
  • 2001年至2002年,担任《Environmental Lawyer》主编。
  • 2000年,担任美国联邦索赔法院高级法官Reginald Gibson的实习生。

会员身份

  • 国家律师协会(知识产权委员会,《Newsletter》网络研讨会协调员和编辑,2013年;财务主管,2014年;秘书,2015-2016年;执行委员会成员,2017年)
  • 妇女律师协会(联席主席,工作家长委员会,2013年至今;联席主席,知识产权委员会,2016年至今)
  • 美国国际贸易委员会审判律师协会(编辑,《Section 337 Reporter》,暑期助理版,2013-2016年,执行委员会成员,2017年)

经验

Eli Lilly and Company v. Actavis Labs. UT Inc.

Represented Eli Lilly in patent litigation relating to Cialis®.

1:16-cv-01119, E.D. Va., Judges Nachmanoff, Trenga

Actelion Pharmaceuticals v. ICOS Corp.

Represented ICOS in Patent Trial and Appeal Board (PTAB) proceeding involving pharmaceutical formulation.

IPR2015-00561, -00562, PTAB, Judges Mitchell, Snedden, Yang

Eli Lilly and Company v. Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center

Represented Eli Lilly in an appeal from a PTAB decision in an IPR case.

IPR2014-00693, -00752, PTAB, Judges Green, Prats, Snedden
16-1547, Fed. Cir., Judges Bryson, Moore, Newman

Nippon Steel & Sumitomo Metal Corp. v. POSCO

Defended POSCO in a patent infringement action involving grain oriented steel.

2:12-cv-02429, D.N.J., Judges Cavanaugh, Chesler, Falk, Waldor
15-0112, Fed. Cir., Judges Dyk, Hughes, Newman

In Re Certain Polycrystalline Diamond Compacts and Articles Containing Same

Secured a decisive victory for client US Synthetic Corp. (USS) at the ITC. After a full hearing, the ALJ found that respondents infringed multiple claims of USS’s patent and that the claims were valid and supported by a domestic industry, but an initial Commission ruling under § 101 temporarily prevented a finding of violation of Section 337. The Federal Circuit reversed the § 101 ruling, and on remand the ITC found a violation and issued a limited exclusion order barring infringing polycrystalline diamond products from entry into the United States, securing final relief for USS.

337-TA-1236, ITC, Judge Elliot

Certain Drug Products Containing C-Type Natriuretic Peptide Variants, and Components Thereof

Representing respondent Wacker Biotech GmbH in a rare section 337 ITC investigation involving drug products containing C-type natriuretic peptide variants.

337-TA-1447, ITC, Judge Cheney

More

专业见解

Conference

International Trade Commission Litigation & Enforcement International Trade Commission Litigation & Enforcement

May 4-5, 2026

Washington, DC

Conference

2026 American Bar Association-Intellectual Property Law Section Annual Meeting 2026 American Bar Association-Intellectual Property Law Section Annual Meeting

April 15-16, 2026

Washington, DC

Articles

Why Fashion Brands are Doubling Down on US Utility Patents

Why Fashion Brands are Doubling Down on US Utility Patents Why Fashion Brands are Doubling Down on US Utility Patents

March 10, 2026

World Trademark Review

Articles

Your Best Bet for Enforcement: Schedule A Cases or Section 337 Investigations?

Your Best Bet for Enforcement: Schedule A Cases or Section 337 Investigations? Your Best Bet for Enforcement: Schedule A Cases or Section 337 Investigations?

November 27, 2025

World Trademark Review

Event

Patent Litigation Developments and Strategies in Europe and the U.S.: ITC and UPC Practices - Shanghai

Patent Litigation Developments and Strategies in Europe and the U.S.: ITC and UPC Practices - Shanghai Patent Litigation Developments and Strategies in Europe and the U.S.: ITC and UPC Practices - Shanghai

November 7, 2025

Shanghai

Seminar

Patent Litigation Developments and Strategies in Europe and U.S.: ITC and UPC Practices - Beijing

Patent Litigation Developments and Strategies in Europe and U.S.: ITC and UPC Practices - Beijing Patent Litigation Developments and Strategies in Europe and U.S.: ITC and UPC Practices - Beijing

November 4, 2025

Beijing

More

职业奖项

“Mareesa Frederick is especially noted for her work before the ITC, regularly leading complex investigations.”

Intellectual Asset Management Patent 1000

"Frederick has a sterling track record at the ITC, where she previously worked as a senior investigative attorney."

Intellectual Asset Management Patent 1000

“Mareesa Frederick is 'deeply familiar with the ITC practice and greatly contributes to the resolution of complicated problems, which occasionally arise during ITC proceedings.’”

Legal 500 United States

“Frederick, who also benefits from inside knowledge, recently won a rare complete victory on summary determination for REC Solar Holdings as respondent in a high-profile investigation involving solar cells.”

Intellectual Asset Management Patent 1000

“Mareesa Frederick is especially noted for her work before the ITC, regularly leading complex investigations.”

Intellectual Asset Management Patent 1000

"Frederick has a sterling track record at the ITC, where she previously worked as a senior investigative attorney."

Intellectual Asset Management Patent 1000

“Mareesa Frederick is 'deeply familiar with the ITC practice and greatly contributes to the resolution of complicated problems, which occasionally arise during ITC proceedings.’”

Legal 500 United States

“Frederick, who also benefits from inside knowledge, recently won a rare complete victory on summary determination for REC Solar Holdings as respondent in a high-profile investigation involving solar cells.”

Intellectual Asset Management Patent 1000

新闻

Award/Ranking

Finnegan Earns Top Rankings in the 2026 Legal 500 U.S. Guide Finnegan Earns Top Rankings in the 2026 Legal 500 U.S. Guide

June 10, 2026

The Legal 500

Award/Ranking

Finnegan Earns Top Rankings in 2026 IAM Patent 1000 Guide; Nearly 60 Attorneys Ranked Finnegan Earns Top Rankings in 2026 IAM Patent 1000 Guide; Nearly 60 Attorneys Ranked

May 28, 2026

Intellectual Asset Management (IAM)

Award/Ranking

61 Finnegan Attorneys Recognized on the 2025 Capital Pro Bono Honor Roll 61 Finnegan Attorneys Recognized on the 2025 Capital Pro Bono Honor Roll

May 7, 2026

Commentary

How Litigation Funding Disclosure Could Affect ITC Cases How Litigation Funding Disclosure Could Affect ITC Cases

May 7 , 2026

Law360

Commentary

Patent Cases Down 64% YOY at PTAB, up 70% at ITC in Q1 2026 Patent Cases Down 64% YOY at PTAB, up 70% at ITC in Q1 2026

April 15, 2026

Intellectual Asset Management (IAM)

Commentary

ITC Commissioner Nominations Could Create a Republican Majority ITC Commissioner Nominations Could Create a Republican Majority

February 13, 2026

Intellectual Asset Management (IAM)
More

会员身份

  • National Bar Association
    (member of Executive Board, 2017; secretary, 2015-2016; treasurer, 2014; webinar coordinator and editor IP Newsletter, Intellectual Property Committee, 2013)
  • International Trade Commission Trial Lawyers Association
    (member of Executive Committee, 2017-present; editor, Section 337 Reporter, Summer Associate edition, 2013-2016)
  • Women’s Bar Association (WBA)
    (Women of Color Task Force, 2019-present; co-chair, IP Committee, 2016-2018; co-chair, Working Parents Committee, 2013-2018)
  • Intellectual Property Owners Association
    (chair, Diversity Outreach Committee, 2024-2025; co-chair, Diversity Outreach Committee, 2021-2023; Women in IP Law, 2018-2019)
  • American Bar Association
    (editorial board member, Landslide, 2024-2026; vice chair, International Trade Commission Committee, 2024-2025; Business Law fellow, Business Law Section, 2018-2020; Business Law Fellow, Business Law Section, 2018-2020)
  • American Intellectual Property Law Association
    (Editorial Board, AIPLA Quarterly Journal, 2018-2021)
  • Alfred Street Baptist Church
    (council member, Legal & Governance Committee, 2018-present)
  • Only Make Believe
    (board member, 2022-present)
Admissions and Education

律师协会

  • U.S. Patent and Trademark Office
  • District of Columbia
  • Virginia
  • District of Columbia
  • U.S. Patent and Trademark Office
  • U.S. Court of Appeals, Federal Circuit

教育背景

George Washington University Law School
J.D., with honors, 2002
Georgia Institute of Technology
B.S., Chemical Engineering, 1997
Spelman College
B.S., Chemistry, magna cum laude, 1997

Mareesa律师的业务领域

AI + Finnegan
AI + Patent
AI + Trade Secrets
尽职调查、许可和意见
自由运作意见
全球知识产权维权、诉讼与审判
原研药哈奇-维克斯曼(ANDA)诉讼与审判
外观设计知识产权
美国国际贸易委员会337调查与审判
专利诉讼与审判
审前策略
商业秘密
商标诉讼与审判
专利局无效程序
PTAB无效程序:双方复审及授权后复审
知识产权申办及组合管理
外观设计知识产权
尽职调查
意见及咨询
专利撰写与申办
商标及品牌管理
外观设计知识产权
商标诉讼与审判

Mareesa律师的行业领域

电子和信息科技
人工智能(AI)和机器学习(ML)
电子与计算机技术
化学、工业和材料
化学
工业制造
纺织品
消费品和服务业
消费品
食品和饮料
能源
石油和天然气
生命科学
生物技术
数字医疗
医疗设备与诊断
制药
运输和物流
汽车

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • 隐私
  • 免责申明
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP